Guardant Health, Inc. (GH) Share-based Payment Arrangement, Expense USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Guardant Health, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Guardant Health, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $27 M, a 21.4% increase year-over-year.
  • Guardant Health, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $95.5 M, a 3.67% increase year-over-year.
  • Guardant Health, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $90.8 M, a 4.15% decline from 2022.
  • Guardant Health, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $94.7 M, a 37.5% decline from 2021.
  • Guardant Health, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $151 M, a 5.09% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $95.5 M $27 M +$4.78 M +21.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $90.8 M $24.3 M +$617 K +2.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $90.1 M $21.8 M +$1.18 M +5.72% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $89 M $22.4 M -$3.19 M -12.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $92.2 M $22.3 M -$2.53 M -10.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $94.7 M $23.7 M -$3.15 M -11.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $97.8 M $20.6 M -$14.4 M -41.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $112 M $25.5 M -$8.96 M -26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $121 M $24.8 M -$30.3 M -55% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $151 M $26.9 M -$29.9 M -52.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $181 M $35 M -$20.2 M -36.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $202 M $34.5 M +$8.69 M +33.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $193 M $55.1 M +$48.7 M +769% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $144 M $56.8 M +$51.7 M +1019% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $92.4 M $55.2 M +$49.7 M +907% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $42.7 M $25.8 M +$22.6 M +703% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $20.1 M $6.34 M +$3.16 M +99.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $17 M $5.07 M +$2.51 M +97.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $14.4 M $5.48 M +$3.65 M +200% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $10.8 M $3.22 M +$2.04 M +172% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $8.76 M $3.18 M +$1.91 M +149% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $6.85 M $2.56 M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $1.83 M +$1.02 M +127% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.18 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.28 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $808 K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.